ライフサイエンスコーパス: sclerotherapy

1 benefit for combination therapy (banding and sclerotherapy).

2 ar veins within 60 days after treatment with sclerotherapy.

3 an unusual but not rare complication of STS sclerotherapy.

4 t potentially serious complication of venous sclerotherapy.

5 ding has been shown to be superior to needle sclerotherapy.

6 osts and lower recurrent bleeding rates than sclerotherapy.

7 th saphenous vein insufficiency treated with sclerotherapy.

8 ymphoceles; five of these patients underwent sclerotherapy.

9 phageal varies, TIPS was more effective than sclerotherapy.

10 ctive variceal hemorrhage despite endoscopic sclerotherapy.

11 None of the patients previously underwent sclerotherapy.

12 m esophageal varices than patients receiving sclerotherapy (3 of 24 compared with 12 of 25; P = 0.012

13 Despite urgent sclerotherapy, active variceal hemorrhage has a 70%-90%

14 he treatment of choice for most VMs, but all sclerotherapy agents are associated with the risk of com

15 ness analysis comparing TIPS with endoscopic sclerotherapy and endoscopic ligation for the prevention

16 Ultrasound-guided foam sclerotherapy and endovenous laser ablation are widely u

17 t per bleed prevented for TIPS compared with sclerotherapy and ligation was $8,803 and $12, 660, resp

18 uidance and monitoring of minimally invasive sclerotherapy and permits verification of therapeutic su

19 Endoscopic sclerotherapy and TIPS are equivalent with respect to re

20 8%) and 21 (40.4%) of patients had injection sclerotherapy and variceal band ligation, respectively.

21 n age, 22 mo) underwent primary prophylaxis (sclerotherapy and/or banding, depending on age and weigh

22 iceal bleeding prophylaxis with propranolol, sclerotherapy, and shunt surgery in cirrhotic patients s

23 lacebo (among patients that received initial sclerotherapy/banding before randomization) (RR, 0.46; 9

24 Our results show that sclerotherapy combined with ligation offers no benefit o

25 Combined ligation plus sclerotherapy does not reduce the number of treatment se

26 BEV were randomized to emergency endoscopic sclerotherapy (EEST) (n=106) or EPCS (n=105).

27 Today, endoscopic sclerotherapy (ES) and endoscopic ligation (EL) are the

28 s were performed emergently after endoscopic sclerotherapy failed to stop active bleeding.

29 t (82% distal splenorenal shunts) because of sclerotherapy failure or because endoscopic treatment wa

30 Recurrent variceal hemorrhage was managed by sclerotherapy followed by angiographic assessment of TIP

31 reotide had comparable efficacy to immediate sclerotherapy for control of bleeding (RR, 0.94; 95% CI,

32 ter sclerotherapy was the most common in the sclerotherapy group (n = 10).

33 ollow-up (+/-SE) was 567 +/- 104 days in the sclerotherapy group and 575 +/- 109 days in the TIPS gro

34 e (9 patients in the TIPS group and 8 in the sclerotherapy group), portal gastropathy (1 patient in e

35 g (5 patients in the TIPS group and 3 in the sclerotherapy group), sepsis (3 and 2 patients, respecti

36 he stents (TIPS group) or crossover to TIPS (sclerotherapy group).

37 Patients assigned to repeated sclerotherapy had the procedure weekly.

38 The patients underwent sclerotherapy in a single intervention with either 0.2%

39 me required for minimally invasive MR-guided sclerotherapy in regression analysis, (d) ability of MR

40 Ambulatory sclerotherapy is a safe, viable alternative to conventio

41 Sclerotherapy is the treatment of choice for most VMs, b

42 Although sclerotherapy is the treatment of choice for reticular v

43 The total annual costs per patient for sclerotherapy, ligation, and TIPS were $23,459, $23,111,

44 The number of bleeds per patient for sclerotherapy, ligation, and TIPS would be 0.39, 0.32, a

45 opic sclerotherapy who received prophylactic sclerotherapy, ligation, or TIPS over 1 year.

46 However, sclerotherapy may be superior to TIPS with respect to su

47 A standard endoscopic sclerotherapy needle and sheath filled with 0.9% saline

48 otocol using octreotide or terlipressin with sclerotherapy or band ligation for active bleeding at en

49 bleeding varices not amenable to endoscopic sclerotherapy or banding were prospectively randomized t

50 ifestyle changes) to minimally invasive (eg, sclerotherapy or endoluminal ablation), invasive (surgic

51 t per bleed prevented for TIPS compared with sclerotherapy or ligation was sensitive to the cost of T

52 completed with either ultrasound-guided foam sclerotherapy or local anesthetic phlebectomy.

53 nomalies who underwent ethanol embolization, sclerotherapy, or both.

54 ophylaxis with endoscopic variceal ligation, sclerotherapy, or nonspecific beta-blockade in children

55 er jejunal feeding tubes, stent perforation, sclerotherapy, or surgical or endoscopic trauma.

56 re obliterated more reliably by TIPS than by sclerotherapy (P < 0.001).

57 children had undergone at least one previous sclerotherapy procedure.

58 for this retrospective review, in which 647 sclerotherapy procedures were performed in 204 patients

59 Fourteen percutaneous sclerotherapy procedures with magnetic resonance (MR) im

60 he patients had TIPS placed for acute (2) or sclerotherapy-resistant (3) variceal hemorrhage.

61 Thus, combined ligation and sclerotherapy should not be used to treat patients with

62 Standard sclerotherapy techniques were used.

63 r options to manage acute bleeding episodes (sclerotherapy, TIPS) and advanced liver disease complica

64 Seventy-six percutaneous sclerotherapy treatments were performed by one radiologi

65 ers and receiving microsclerotherapy or foam sclerotherapy treatments, being unwilling to enter into

66 In addition, sclerotherapy was not performed so as to avoid an unnece

67 Percutaneous sclerotherapy was performed successfully and without com

68 Sclerotherapy was performed with bleomycin when daily dr

69 Endoscopic sclerotherapy was preferred for more than a decade, but

70 Sclerotherapy was significantly less cost-effective than

71 PS group (n = 12), and pain developing after sclerotherapy was the most common in the sclerotherapy g

72 hageal or contiguous gastric varices despite sclerotherapy were assessed for risk of dying after emer

73 esophageal variceal bleeding with endoscopic sclerotherapy who received prophylactic sclerotherapy, l

74 ned to study whether combining ligation with sclerotherapy will allow quicker eradication of varices

75 Sclerotherapy with 0.2% polidocanol diluted in 70% HG wa

76 Sclerotherapy with 0.2% polidocanol plus 70% HG was sign

77 erformed comparing combination ligation plus sclerotherapy with ligation alone in patients with major

78 Combining endoscopic sclerotherapy with ligation has been proposed to hasten

79 In conclusion, sclerotherapy with MR imaging guidance can be performed